Association of Hemophagocytic Lymphohistiocytosis and Programmed Death 1 Checkpoint Inhibitors

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.11.035
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Hemophagocytic Lymphohistiocytosis

2020English

Relative Efficacy of Checkpoint Inhibitors for Advanced NSCLC According to Programmed Death-Ligand-1 Expression: A Systematic Review and Network Meta-Analysis

Scientific Reports
Multidisciplinary
2018English

The Prognostic Role of Immune Checkpoint Markers Programmed Cell Death Protein 1 (PD-1) and Programmed Death Ligand 1 (PD-L1) in a Large, Multicenter Prostate Cancer Cohort

Oncotarget
Oncology
2017English

Hemophagocytic Lymphohistiocytosis in Association With Primary Cutaneous Anaplastic Large Cell Lymphoma

Case Reports in Hematology
2014English

Treatment of Advanced Melanoma With Concurrent Radiation and Programmed Cell Death 1 Inhibitors

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Predictive Role of Computed Tomography Texture Analysis in Patients With Metastatic Urothelial Cancer Treated With Programmed Death-1 and Programmed Death-Ligand 1 Inhibitors

European urology oncology
OncologyRadiologyUrologyNuclear MedicineImagingSurgery
2019English

Post-Transfusion Hemophagocytosis Without Hemophagocytic Lymphohistiocytosis

Mayo Clinic Proceedings: Innovations, Quality & Outcomes
2019English

Molecular Pathways: Next-Generation Immunotherapy--Inhibiting Programmed Death-Ligand 1 and Programmed Death-1

Clinical Cancer Research
Cancer ResearchOncology
2012English

Hemophagocytic Lymphohistiocytosis in a Young Child

International Journal Of Medical Science And Clinical Invention
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy